MGI MP annotations for MGI:1097714: Bhlhe40

  • Gray arrows indicate "is_a"



    Compare annotations to MP categories for MGI:1097714.
    IDTermBhlhe40tm1.1RhliBhlhe40tm1Tan
    MP:0005386behavior/neurological phenotypeBhlhe40tm1.1RhliBhlhe40tm1Tan
    MP:0005384cellular phenotypeBhlhe40tm1.1RhliBhlhe40tm1Tan
    MP:0005397hematopoietic system phenotypeBhlhe40tm1.1RhliBhlhe40tm1Tan
    MP:0005387immune system phenotypeBhlhe40tm1.1RhliBhlhe40tm1Tan
    MP:0003631nervous system phenotypeBhlhe40tm1.1RhliBhlhe40tm1Tan
    MP:0005367renal/urinary system phenotypeBhlhe40tm1.1RhliBhlhe40tm1Tan


    Full set of annotations for MGI:1097714
    IDTermAlleleAllelesBackgroundColor Key
    MP:0008076abnormal CD4-positive T cell differentiation Bhlhe40tm1Tan Bhlhe40tm1Tan/Bhlhe40tm1Taneither: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)color key
    MP:0005463abnormal CD4-positive T cell physiology Bhlhe40tm1Tan Bhlhe40tm1Tan/Bhlhe40tm1Taneither: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)color key
    MP:0001828abnormal T cell activation Bhlhe40tm1Tan Bhlhe40tm1Tan/Bhlhe40tm1Taneither: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)color key
    MP:0000716abnormal immune system cell morphology Bhlhe40tm1Tan Bhlhe40tm1Tan/Bhlhe40tm1Taneither: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)color key
    MP:0001790abnormal immune system physiology Bhlhe40tm1Tan Bhlhe40tm1Tan/Bhlhe40tm1Taneither: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)color key
    MP:0008522abnormal lymph node germinal center morphology Bhlhe40tm1Tan Bhlhe40tm1Tan/Bhlhe40tm1Taneither: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)color key
    MP:0005325abnormal renal glomerulus morphology Bhlhe40tm1Tan Bhlhe40tm1Tan/Bhlhe40tm1Taneither: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)color key
    MP:0002425altered susceptibility to autoimmune disorder Bhlhe40tm1Tan Bhlhe40tm1Tan/Bhlhe40tm1Taneither: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)color key
    MP:0005095decreased T cell proliferation Bhlhe40tm1Tan Bhlhe40tm1Tan/Bhlhe40tm1Taneither: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)color key
    MP:0005092decreased double-positive T cell number Bhlhe40tm1Tan Bhlhe40tm1Tan/Bhlhe40tm1Taneither: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)color key
    MP:0008688decreased interleukin-2 secretion Bhlhe40tm1Tan Bhlhe40tm1Tan/Bhlhe40tm1Taneither: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)color key
    MP:0002565delayed circadian phase Bhlhe40tm1Tan Bhlhe40tm1Tan/Bhlhe40tm1TanB6.129-Bhlhe40color key
    MP:0008074increased CD4-positive T cell number Bhlhe40tm1Tan Bhlhe40tm1Tan/Bhlhe40tm1Taneither: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)color key
    MP:0008078increased CD8-positive T cell number Bhlhe40tm1Tan Bhlhe40tm1Tan/Bhlhe40tm1Taneither: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)color key
    MP:0002497increased IgE level Bhlhe40tm1Tan Bhlhe40tm1Tan/Bhlhe40tm1Taneither: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)color key
    MP:0008499increased IgG1 level Bhlhe40tm1Tan Bhlhe40tm1Tan/Bhlhe40tm1Taneither: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)color key
    MP:0004794increased anti-nuclear antigen antibody level Bhlhe40tm1Tan Bhlhe40tm1Tan/Bhlhe40tm1Taneither: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)color key
    MP:0005090increased double-negative T cell number Bhlhe40tm1Tan Bhlhe40tm1Tan/Bhlhe40tm1Taneither: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)color key
    MP:0008481increased spleen germinal center number Bhlhe40tm1Tan Bhlhe40tm1Tan/Bhlhe40tm1Taneither: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)color key
    MP:0008478increased spleen white pulp amount Bhlhe40tm1Tan Bhlhe40tm1Tan/Bhlhe40tm1Taneither: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)color key
    MP:0002906increased susceptibility to pharmacologically induced seizures Bhlhe40tm1.1Rhli Bhlhe40tm1.1Rhli/Bhlhe40tm1.1Rhliinvolves: 129S1/Sv * C57BL/6 * CD-1 * SJLcolor key
    MP:0008102lymph node hyperplasia Bhlhe40tm1Tan Bhlhe40tm1Tan/Bhlhe40tm1Taneither: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)color key
    MP:0000693spleen hyperplasia Bhlhe40tm1Tan Bhlhe40tm1Tan/Bhlhe40tm1Taneither: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)color key
    MP:0000708thymus hyperplasia Bhlhe40tm1Tan Bhlhe40tm1Tan/Bhlhe40tm1Taneither: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)color key